Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
71251-02-0
Molecular formula
C36H62N4
Molecular weight
550.9 g/mol
Drug class
Cationic bispyridine antiseptictopical local anti-infective agent
Mechanism of action
A cationic, surface-active antiseptic that binds to negatively charged microbial cell-wall and membrane components, disrupting membrane integrity and causing leakage of cellular contents. It has broad activity against bacteria and fungi and activity against some enveloped viruses.
Indications / reported uses
Antiseptic cleansing and treatment of skin, mucous membranes and wounds in formulations authorised for the relevant route and site.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Octenidine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Octenidine Permitted Daily Exposure (PDE) report (the Octenidine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Octenidine Occupational Exposure Limit (OEL) report (the Octenidine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.